Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
Objective: To identify factors associated with mortality in SLE patients who were hospitalized for pulmonary infections (PIs).Methods: This single-center retrospective study analyzed the characteristics and risk factors for mortality in 95 SLE patients hospitalized for PIs.Results: Ninety-five SLE p...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.732681/full |
id |
doaj-6e2265abcc054da2af9aa940d1eda5df |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yanli Yang Yanli Yang Hui Jiang Chuhan Wang Nan Jiang Chanyuan Wu Shangzhu Zhang Wei Jiang Jinmin Peng Li Weng Jiuliang Zhao Qian Wang Mengtao Li Bin Du Yan Zhao Xiaofeng Zeng |
spellingShingle |
Yanli Yang Yanli Yang Hui Jiang Chuhan Wang Nan Jiang Chanyuan Wu Shangzhu Zhang Wei Jiang Jinmin Peng Li Weng Jiuliang Zhao Qian Wang Mengtao Li Bin Du Yan Zhao Xiaofeng Zeng Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections Frontiers in Medicine systemic lupus erythematosus pulmonary infection mortality risk factor cardiopulmonary involvement opportunistic infection |
author_facet |
Yanli Yang Yanli Yang Hui Jiang Chuhan Wang Nan Jiang Chanyuan Wu Shangzhu Zhang Wei Jiang Jinmin Peng Li Weng Jiuliang Zhao Qian Wang Mengtao Li Bin Du Yan Zhao Xiaofeng Zeng |
author_sort |
Yanli Yang |
title |
Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections |
title_short |
Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections |
title_full |
Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections |
title_fullStr |
Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections |
title_full_unstemmed |
Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections |
title_sort |
clinical characteristics and prognoses of patients with systemic lupus erythematosus hospitalized for pulmonary infections |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2021-09-01 |
description |
Objective: To identify factors associated with mortality in SLE patients who were hospitalized for pulmonary infections (PIs).Methods: This single-center retrospective study analyzed the characteristics and risk factors for mortality in 95 SLE patients hospitalized for PIs.Results: Ninety-five SLE patients had 97 episodes of hospitalization for PIs, and 33 of these episodes (34.02%) led to death. Death from PI was associated with a higher neutrophil count (6.30 vs. 4.201 × 109/L, p < 0.01), immunoglobulin G (6.20 vs. 9.82 g/L, p = 0.01), serum creatinine (126.00 vs. 73.00 μmol/L, p = 0.01), proteinuria (2.99 vs. 0.54 g/day, p < 0.01), cardiopulmonary involvement (57.58 vs. 34.38%, p < 0.05), SLE disease activity index (SLEDAI; 11.00 vs. 6.00, p < 0.05), and opportunistic infections (78.79 vs. 45.31%, p < 0.05). Demographic characteristics, antibody/complements, bacterial infection, and primary treatment before infection (including corticosteroid and immunosuppressants) had no effect. Multivariate analysis indicated cardiopulmonary involvement (HR: 2.077; 95%CI: 1.022–4.220; p = 0.043) and opportunistic infection (HR: 2.572; 95%CI: 1.104–5.993; p = 0.029) were independent risk factors for mortality. High-dose steroid pulse therapy (HR: 0.982; 95%CI: 0.410–2.350; p = 0.982) and first-line immunosuppressant therapy (HR: 1.635; 95%CI: 0.755–3.542, p = 0.212) had no effect on mortality.Conclusion: Cardiopulmonary involvement and opportunistic infection were independent risk factors for mortality for SLE patients hospitalized for PIs. Use of high-dose pulse steroids and or immunosuppressants before hospitalization had no significant effects. |
topic |
systemic lupus erythematosus pulmonary infection mortality risk factor cardiopulmonary involvement opportunistic infection |
url |
https://www.frontiersin.org/articles/10.3389/fmed.2021.732681/full |
work_keys_str_mv |
AT yanliyang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT yanliyang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT huijiang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT chuhanwang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT nanjiang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT chanyuanwu clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT shangzhuzhang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT weijiang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT jinminpeng clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT liweng clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT jiuliangzhao clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT qianwang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT mengtaoli clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT bindu clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT yanzhao clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections AT xiaofengzeng clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections |
_version_ |
1716864709728141312 |
spelling |
doaj-6e2265abcc054da2af9aa940d1eda5df2021-09-29T05:02:56ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-09-01810.3389/fmed.2021.732681732681Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary InfectionsYanli Yang0Yanli Yang1Hui Jiang2Chuhan Wang3Nan Jiang4Chanyuan Wu5Shangzhu Zhang6Wei Jiang7Jinmin Peng8Li Weng9Jiuliang Zhao10Qian Wang11Mengtao Li12Bin Du13Yan Zhao14Xiaofeng Zeng15Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaShanxi Bethune Hospital, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Taiyuan, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Medicine Intensive Care Unit, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Medicine Intensive Care Unit, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Medicine Intensive Care Unit, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaObjective: To identify factors associated with mortality in SLE patients who were hospitalized for pulmonary infections (PIs).Methods: This single-center retrospective study analyzed the characteristics and risk factors for mortality in 95 SLE patients hospitalized for PIs.Results: Ninety-five SLE patients had 97 episodes of hospitalization for PIs, and 33 of these episodes (34.02%) led to death. Death from PI was associated with a higher neutrophil count (6.30 vs. 4.201 × 109/L, p < 0.01), immunoglobulin G (6.20 vs. 9.82 g/L, p = 0.01), serum creatinine (126.00 vs. 73.00 μmol/L, p = 0.01), proteinuria (2.99 vs. 0.54 g/day, p < 0.01), cardiopulmonary involvement (57.58 vs. 34.38%, p < 0.05), SLE disease activity index (SLEDAI; 11.00 vs. 6.00, p < 0.05), and opportunistic infections (78.79 vs. 45.31%, p < 0.05). Demographic characteristics, antibody/complements, bacterial infection, and primary treatment before infection (including corticosteroid and immunosuppressants) had no effect. Multivariate analysis indicated cardiopulmonary involvement (HR: 2.077; 95%CI: 1.022–4.220; p = 0.043) and opportunistic infection (HR: 2.572; 95%CI: 1.104–5.993; p = 0.029) were independent risk factors for mortality. High-dose steroid pulse therapy (HR: 0.982; 95%CI: 0.410–2.350; p = 0.982) and first-line immunosuppressant therapy (HR: 1.635; 95%CI: 0.755–3.542, p = 0.212) had no effect on mortality.Conclusion: Cardiopulmonary involvement and opportunistic infection were independent risk factors for mortality for SLE patients hospitalized for PIs. Use of high-dose pulse steroids and or immunosuppressants before hospitalization had no significant effects.https://www.frontiersin.org/articles/10.3389/fmed.2021.732681/fullsystemic lupus erythematosuspulmonary infectionmortalityrisk factorcardiopulmonary involvementopportunistic infection |